Jointly provided by Medical Education Resources and Impact Education, LLC.
|
This activity is supported by an independent educational grant from Dexcom, Inc Medical Affairs.
|
Dinner, drinks, and complimentary parking provided by Impact Education, LLC.
Thursday, June 18, 2026
5:30 PM - 6:00 PM - Registration and Reception
6:00 PM - 8:00 PM - Dinner and Presentation
Tavola
823 5th Ave S
Minneapolis, MN 55404
(Located in the Elliot Park Hotel)
|
|
|
Expert Faculty
|
|
The program will feature a multidisciplinary panel including a diabetes expert clinician and regional managed care/payer experts.
|
|
Who Should Attend?
|
This activity is designed to meet the educational needs of AMCP Midwest affiliate members in the roles of pharmacy directors, clinical pharmacists, specialty pharmacists, medical directors, nurses, quality directors, and other managed care professionals.
|
|
Statement of Need/Program Overview
|
Continuous glucose monitoring (CGM) has become an increasingly integral component of diabetes management, supported by a growing body of evidence demonstrating improvements in glycemic control, reductions in hypoglycemia, and enhanced patient engagement. This program will provide you with a comprehensive overview of the evolving role of CGM across the diabetes care continuum. The expert faculty will review current standards of care and guideline recommendations, highlighting how CGM supports therapy initiation and treatment optimization. The discussion will also explore the implications of emerging evidence, along with recent HEDIS and Stars updates, to inform payer strategies around coverage, utilization management, and population health approaches aimed at improving outcomes and quality performance at both the individual and population levels.
|
|
Educational Objectives
|
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Describe current standards of care and guideline recommendations for CGM, including its role in therapy initiation and treatment optimization across diabetes care pathways
- Evaluate clinical, real-world, and economic evidence on CGM and its association with glycemic outcomes, quality measure attainment, healthcare utilization, and payer-relevant cost outcomes, including among individuals with non-insulin-treated type 2 diabetes
- Assess the implications of emerging evidence, HEDIS and Stars updates, and CGM-based individual- and population-level care approaches for managed care decision-making, including quality performance, coverage policy, utilization management, and population health strategies
|
|
Accreditation Information
|
|
Joint Accreditation Statement |
 |
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Impact Education, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
|
|
Physician Continuing Medical Education
Medical Education Resources designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
Continuing Pharmacy Education
Medical Education Resources designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
UAN: JA0003680-9999-26-220-L01-P
This activity is certified as Knowledge-based CPE.
Please note: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.
|
Continuing Nursing Education
Medical Education Resources designates this live activity for a maximum of 1.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.
|
Disclosure of Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Impact Education, LLC, and/or Dexcom, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee Information
There is no fee for this educational activity.
|
| |
